Search

Following a thorough safety review, including two meetings of the CDC’s Advisory Committee on Immunization Practices, the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Janssen (Johnson & Johnson) COVID-19 Vaccine in the U.S. should be lifted and use of the vaccine should resume.

Harvard Book Store and the Cambridge Public Library welcome LYDIA MILLET—author of the National Book Award finalist A Children's Bible and the Pulitzer Prize finalist Love in Infant Monkeys—for a discussion of her new anti-memoir We Loved it All: A Memory of Life. She will be joined in conversation by TERRY TEMPEST WILLIAMS—Writer-in-Residence at the Harvard Divinity School and award-winning author of Refuge, Erosion, and When Women Were Birds. Registration required through Harvard Book Store. https://www.harvard.com/event/lydia_millet2/

Building a brand is personal and targeted, whether offline or online.

In this webinar you will learn hoe to get started on the process of taking your brand online.

Legislature passed a law increasing from 7 to 9 the number of off-premises (§ 15) licenses any person or combination of persons may hold, directly or indirectly, in MA, starting January 1, 2020.

Apply for a Pole and Conduit Petition Online

Online Application to apply for a Fortune Teller License

Online Application to apply for a Hawker Peddler License

Shopify is an e-commerce platform that has everything you need to sell online, on social media, or in person

Today (August 23, 2021), the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.